Odyssey Health, Inc. financial data

Symbol
ODYY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
2300 West Sahara Avenue, Suite 800 #4012, Las Vegas, Nevada
State of incorporation
Nevada
Fiscal year end
July 31
Former names
Odyssey Group International, Inc. (to 2/18/2022)
Latest financial report
10-Q - Q1 2024 - Jun 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.64 % -38.1%
Debt-to-equity -118 % +29.1%
Return On Equity 1.06K % +692%
Return On Assets 155 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.4M shares +22.7%
Common Stock, Shares, Outstanding 96.4M shares +23.4%
Entity Public Float 11M USD -65.4%
Common Stock, Value, Issued 96.4K USD +23.4%
Weighted Average Number of Shares Outstanding, Basic 104M shares +24.8%
Weighted Average Number of Shares Outstanding, Diluted 104M shares +24.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 25.8K USD
General and Administrative Expense 1.28M USD -36.5%
Operating Income (Loss) -3.03M USD +53.3%
Net Income (Loss) Attributable to Parent 11.1M USD +34.4%
Earnings Per Share, Basic 0.12 USD/shares +50%
Earnings Per Share, Diluted 0.1 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66K USD +5250%
Assets, Current 153K USD -60.4%
Property, Plant and Equipment, Net 0 USD -100%
Assets 13.6M USD +3014%
Accounts Payable, Current 1.3M USD -32.2%
Accrued Liabilities, Current 13.8K USD 0%
Liabilities, Current 5.7M USD -8.95%
Liabilities 4.7M USD +95.7%
Retained Earnings (Accumulated Deficit) -48.3M USD +18.6%
Stockholders' Equity Attributable to Parent 7.88M USD
Liabilities and Equity 13.6M USD +3014%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -59.9K USD +79%
Net Cash Provided by (Used in) Financing Activities 221K USD -18.4%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.4M shares +23.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66K USD +5250%
Deferred Tax Assets, Valuation Allowance 2.96M USD +19.6%
Deferred Tax Assets, Gross 2.96M USD +19.6%
Payments to Acquire Property, Plant, and Equipment 8.04K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 56M USD +4.99%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 594K USD -6.16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%